Sinopharm
1099.HK
#2297
Rank
โ‚น768.61 B
Marketcap
โ‚น246.30
Share price
0.00%
Change (1 day)
16.36%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.299 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.299 Trillion. In 2024 the company made a revenue of โ‚น7.299 Trillion a decrease over the revenue in the year 2023 that were of โ‚น7.692 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.299 T-5.1%
2023โ‚น7.692 T5.42%
2022โ‚น7.296 T-2.1%
2021โ‚น7.452 T16.85%
2020โ‚น6.377 T14.95%
2019โ‚น5.548 T21.52%
2018โ‚น4.565 T5.93%
2017โ‚น4.310 T27.22%
2016โ‚น3.387 T5.37%
2015โ‚น3.215 T9.14%
2014โ‚น2.945 T17.22%
2013โ‚น2.513 T25.94%
2012โ‚น1.995 T34.61%
2011โ‚น1.482 T55.34%
2010โ‚น954.28 B35.79%
2009โ‚น702.77 B37.56%
2008โ‚น510.89 B31.43%
2007โ‚น388.73 B40.26%
2006โ‚น277.14 B